Lv2
150 积分 2022-10-17 加入
A phase 2, proof-of-concept, placebo-controlled, randomized, multicenter, double-blind study to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of Usnoflast (ZYIL1) in patients with amyotrophic lateral sclerosis
8天前
已完结
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZY‐IL1 in Three Patients with Cryopyrin‐Associated Periodic Syndromes
8天前
已完结
The neuroinflammatory astrocytic P2X7 receptor: Alzheimer’s disease, ischemic brain injury, and epileptic state
9天前
已完结
P2X7 receptor in inflammation and pain
9天前
已完结
The analgesic effects of ulinastatin either as a single agent or in combination with sufentanil: A novel therapeutic potential for postoperative pain
9天前
已完结
Phytol from Faeces Bombycis alleviated migraine pain by inhibiting Nav1.7 sodium channels
10天前
已完结
The complement system: Biology, pathology, and therapeutic interventions
13天前
已完结
A guide to complement biology, pathology and therapeutic opportunity
13天前
已完结
Recent advances in colony stimulating factor-1 receptor (CSF1R) inhibitors
13天前
已完结
Menthol preferentially inhibits persistent Na+ current mediated by NaV1.8 in small-sized dural afferent neurons of rats
14天前
已完结
皖公网安备34019202002308
